Why the study?
Does rapid measurement of B-type natriuretic peptide improve establishing or excluding the diagnosis of congestive heart failure in patients with acute dyspnea?
Does rapid measurement of B-type natriuretic peptide improve establishing or excluding the diagnosis of congestive heart failure in patients with acute dyspnea?
Rapid BNP measurement, when used with other clinical information, is a useful diagnostic tool for evaluating heart failure in patients presenting with acute dyspnea.
Supports BNP testing to aid HF diagnosis in acute dyspnea; leaves open effects on management and outcomes.
Used in conjunction with other clinical information, rapid measurement of B-type natriuretic peptide is useful in establishing or excluding the diagnosis of congestive heart failure in patients with acute dyspnea.
No takes yet. Share an insight, caveat, or question.
Maisel et al. (2002) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: